IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB)

Historical Holders from Q3 2021 to Q3 2025

Symbol
INAB on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
3.45M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
287K
Holdings value
$622K
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Fund II, LP 9.99% $1.64M 9.12M BIOS CAPITAL MANAGEMENT, LP 02 May 2025
Ho William Tai-Wei 5.6% $738K 4.1M William Tai-Wei Ho 31 Dec 2024
HIRSCHMAN ORIN 4.4% -45.6% $18K -$725K 150K -97.6% Orin Hirschman 30 Jun 2025
Alyeska Investment Group, L.P. 2.58% -73.2% $186K -$14.9M 89K -98.8% Alyeska Investment Group, L.P. 30 Jun 2025

Institutional Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 287K $622K $2.17 1
2025 Q2 287K $599K -$19.5M $2.09 1
2025 Q1 21.7M $3.6M -$1.47M $0.17 28
2024 Q4 30M $7.72M +$3.54M $0.26 25
2024 Q3 7.63M $2.06M -$108K $0.27 25
2024 Q2 7.1M $6.01M -$1.01M $0.85 24
2024 Q1 8.64M $10.2M +$62.5K $1.18 31
2023 Q4 8.58M $11.4M +$7.98M $1.38 29
2023 Q3 2.48M $2.58M +$96.5K $1.04 20
2023 Q2 2.33M $3.59M +$1.48M $1.54 21
2023 Q1 1.37M $1.78M +$205K $1.30 16
2022 Q4 1.21M $2.79M +$42.8K $2.31 16
2022 Q3 1.2M $2.42M -$2.88M $2.02 15
2022 Q2 2.36M $5.5M +$644K $2.26 14
2022 Q1 2.05M $7.02M +$918K $3.38 13
2021 Q4 1.78M $7.8M -$314K $4.39 12
2021 Q3 1.77M $12.2M +$12.2M $6.88 11